Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm?

ABSTRACT Lisdexamfetamine, a prodrug used to treat Attention Deficit/Hyperactivity Disorder in children, adolescents, and adults, is an inactive substance that is converted into its active form (dextroamphetamine) after being metabolized. This conversion primarily occurs in the bloodstream through e...

Descrición completa

Detalles Bibliográficos

Principais autores:	Rubens Pitliuk, Tatyanny Paula Pinto da Costa Santos Fucci
Formato:	Artigo
Idioma:	Inglês
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2025-10-01
Series:	Einstein (São Paulo)
Assuntos:	Attention deficit disorder with hyperactivity Raynaud disease Lisdexamfetamine Drug therapy Attention deficit disorders Dizziness Vasospasm, intracranial
Acceso en liña:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100515&tlng=en
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!